Establishment and verification of a prognostic risk score model based on immune genes for hepatocellular carcinoma in an Asian population.

Publication Year: 2023

DOI:
10.21037/tcr-23-128

PMCID:
PMC10643976

PMID:
37969383

Journal Information

Full Title: Transl Cancer Res

Abbreviation: Transl Cancer Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tcr.amegroups.com/article/view/10.21037/tcr-23-128/coif). The authors have no conflicts of interest to declare."

Evidence found in paper:

"Funding: The current study was supported by grants from the international team of gastrointestinal tumor project funding ( No. SZYJTD201804 ), import team of hepatobiliary and pancreatic surgery project funding ( No. SZYJTD201803 ), the project of State Key Laboratory of Radiation Medicine and Protection ( No. GZK1202007 ), The Second Affiliate Hospital of Soochow University science and technology innovation team project funding ( No. XKTJ-TD202009 ) and the Natural Science Foundation of the Jiangsu Higher Education Institutions of China ( No. 21KJB310006 )."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025